Fenfluramine Hydrochloride

CAS 434-03-7 5 API suppliersSmall Molecule

Overview

Fenfluramine Hydrochloride is a pharmaceutical drug that was originally used as an appetite suppressant in the treatment of obesity. It is currently approved for use in the treatment of seizures associated with Dravet syndrome.

API suppliers (5)

Suppliers of Fenfluramine Hydrochloride evidenced by a US FDA Type II Drug Master File or an EU Certificate of Suitability (CEP). Sources: FDA DMF list, EDQM certification database.

Where these suppliers are
India1Italy1

Country recorded for 2 of 5 suppliers.

2 of 5 hold a GMP certificate on record in the EU or UK registers

Therapeutic areas

NeurologyObesity
Verified Supplier Partner

Do you supply Fenfluramine Hydrochloride? Get in front of buyers actively sourcing it.

We route real sourcing requests from pharma buyers to vetted, verified partners — qualified leads, not just a listing. Tell us what you make and we'll be in touch about becoming a Verified Supplier Partner.

No cost to enquire · we only reach out with a fit.

Ready to Accelerate Your
Discovery Workflow?

Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 7 days.